Home > Publications Database > Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities. > print

001     278093
005     20260105131120.0
024 7 _ |a pmc:PMC12183968
|2 pmc
024 7 _ |a 10.1016/j.tjpad.2025.100098
|2 doi
024 7 _ |a pmid:40102145
|2 pmid
024 7 _ |a 2274-5807
|2 ISSN
024 7 _ |a 2426-0266
|2 ISSN
024 7 _ |a altmetric:175328884
|2 altmetric
037 _ _ |a DZNE-2025-00579
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Frisoni, Giovanni B
|b 0
245 _ _ |a Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities.
260 _ _ |a Cham
|c 2025
|b Springer International Publishing
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1747313293_2562
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a A European Task Force has recently developed and published the concept and protocols for the setup of the innovative health offer of Brain Health Services for the secondary prevention of dementia and cognitive impairment (dBHS). dBHS are outpatient health care facilities where adult persons can find an assessment of their risk of developing cognitive impairment and dementia, have their risk level and contributing factors communicated using appropriate language supported by adequate communication tools, can decide to participate to programs for personalized risk reduction if at higher risk, and benefit from cognitive enhancement interventions. This health offer is distinct from that of currently active memory clinics. The ultimate aim of dBHS is to extend healthy life, free from cognitive impairment. Here, we (i) discuss the pertinent opportunities and challenges for those persons who want to benefit from dBHS, professionals, and wider society, (ii) describe the concepts, protocols, organizational features, and patient journeys of some currently active dBHS in Europe, and (iii) argue in favor of the business case for dBHS in Europe.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Brain health services (dBHS)
|2 Other
650 _ 7 |a Dementia
|2 Other
650 _ 7 |a Preventive healthcare
|2 Other
650 _ 7 |a Public health
|2 Other
650 _ 7 |a Secondary prevention
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Dementia: prevention & control
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: prevention & control
|2 MeSH
650 _ 2 |a Secondary Prevention: methods
|2 MeSH
650 _ 2 |a Europe
|2 MeSH
700 1 _ |a Ribaldi, Federica
|b 1
700 1 _ |a Allali, Gilles
|b 2
700 1 _ |a Bieth, Théophile
|b 3
700 1 _ |a Brioschi Guevara, Andrea
|b 4
700 1 _ |a Cappa, Stefano
|b 5
700 1 _ |a Cipolotti, Lisa
|b 6
700 1 _ |a Frederiksen, Kristian Steen
|b 7
700 1 _ |a Georges, Jean
|b 8
700 1 _ |a Jessen, Frank
|0 P:(DE-2719)2000032
|b 9
|u dzne
700 1 _ |a Koch, Giacomo
|b 10
700 1 _ |a Masters, Hugh
|b 11
700 1 _ |a Mendes, Augusto J
|b 12
700 1 _ |a Frölich, Lutz
|b 13
700 1 _ |a Garibotto, Valentina
|b 14
700 1 _ |a Grau-Rivera, Oriol
|b 15
700 1 _ |a Pozzi, Federico E
|b 16
700 1 _ |a Religa, Dorota
|b 17
700 1 _ |a Rostamzadeh, Ayda
|b 18
700 1 _ |a Shallcross, Lenny
|b 19
700 1 _ |a Shenkin, Susan D
|b 20
700 1 _ |a van der Flier, Wiesje M
|b 21
700 1 _ |a Vernooij, Meike W
|b 22
700 1 _ |a Visser, Leonie N C
|b 23
700 1 _ |a Cummings, Jeffrey L
|b 24
700 1 _ |a Scheltens, Philip
|b 25
700 1 _ |a Dubois, Bruno
|b 26
700 1 _ |a Moro, Elena
|b 27
700 1 _ |a Bassetti, Claudio L A
|b 28
700 1 _ |a Kivipelto, Miia
|b 29
773 _ _ |a 10.1016/j.tjpad.2025.100098
|g Vol. 12, no. 5, p. 100098 -
|0 PERI:(DE-600)2782183-3
|n 5
|p 100098
|t The journal of prevention of Alzheimer's disease
|v 12
|y 2025
|x 2274-5807
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/278093/files/DZNE-2025-00579.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/278093/files/DZNE-2025-00579.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:278093
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2000032
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-05
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JPAD-J PREV ALZHEIM : 2022
|d 2024-12-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-05
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-05
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-05
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b JPAD-J PREV ALZHEIM : 2022
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-05
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Clinical Alzheimer’s Disease Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1011102
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21